Sucker, Antje <br/><br/>
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions.  [electronic resource] 

 -  Nature communications  05 2017 
 - 15440 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/ncomms15440  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigen Presentation--genetics<br/>Antigens, Neoplasm--immunology<br/>Antineoplastic Agents, Immunological--pharmacology<br/>Biopsy<br/>Cell Line, Tumor<br/>DNA Mutational Analysis<br/>Datasets as Topic<br/>Drug Resistance, Neoplasm--genetics<br/>Histocompatibility Antigens Class I--immunology<br/>Humans<br/>Immunotherapy--methods<br/>Interferon-gamma--immunology<br/>Janus Kinase 1--genetics<br/>Janus Kinase 2--genetics<br/>Melanoma--drug therapy<br/>Mutation<br/>Mutation Rate<br/>Patient-Specific Modeling<br/>Precision Medicine--methods<br/>Signal Transduction--genetics<br/>Skin--pathology<br/>Skin Neoplasms--drug therapy<br/>T-Lymphocytes--immunology<br/>Treatment Outcome<br/>Tumor Escape--genetics<br/>Whole Genome Sequencing